Borneo Bulletin'Gift of life' makes joint blood donation campaign a successBorneo BulletinNBT staff, customers, business associates and members of the public turned up in force to generously donate blood at the joint blood donation campaign org…
Meet the first child in Britain to benefit from a pioneering kidney transplant … – Daily Mail
Daily MailMeet the first child in Britain to benefit from a pioneering kidney transplant …Daily MailDuring the procedure, the patient is given an injection of a drug called Rituximab a month before the transplant to suppress the immune system, stoppi…
Study: DMEK has 15 times lower rejection rate than DSEK – OSN SuperSite
Study: DMEK has 15 times lower rejection rate than DSEKOSN SuperSiteRisk of corneal transplant rejection significantly reduced with DMEK. Ophthalmology, in press. Disclosure: Dr. Price has no relevant financial disclosures. The OSN SuperSite is intende…
Triple-Drug Therapy for IPF Found Unsafe – Medscape
Triple-Drug Therapy for IPF Found UnsafeMedscapeThe combination of prednisone, azathioprine, and N-acetylcysteine (NAC) was considered so unsafe for patients taking it that their arm of the trial was halted prematurely, the NHLBI announced today. The a…
Nabeel Nanuck kidney transplant: 1st child in Britain that didn't require a … – Daily Mail
Daily MailNabeel Nanuck kidney transplant: 1st child in Britain that didn't require a …Daily MailDuring the procedure, the patient is given an injection of a drug called Rituximab a month before the transplant to suppress the immune system, stopp…
AIDS society, 92.7 Big FM host blood donation camp – GreaterKashmir.com (press release)
GreaterKashmir.com (press release)AIDS society, 92.7 Big FM host blood donation campGreaterKashmir.com (press release)Srinagar, Oct 21: The J&K AIDS Prevention Control Society in association with 92.7 Big FM Saturday organized a blood donation camp…
Rituximab Clinical Trial Q&A, Developed by the ME Association – ProHealth
Rituximab Clinical Trial Q&A, Developed by the ME AssociationProHealthby ME Association Following is an informative Q&A on the rituximab ME/CFS trial, the drug, and future research issues posted Oct 20 by Tony Britton & Dr. Charles Shepherd…
Biogen Idec und Abbott präsentieren positive Daten für Daclizumab HYP aus der … – Business Wire (Pressemitteilung)
Business Wire (Pressemitteilung)Biogen Idec und Abbott präsentieren positive Daten für Daclizumab HYP aus der …Business Wire (Pressemitteilung)SELECT ist die erste von zwei Zulassungsstudien, mit denen das Prüfpräparat Daclizumab High-Yield Proce…
The Zacks Analyst Blog Highlights: Abbott Labs, Bristol-Myers Squibb, Biogen … – Sacramento Bee
The Zacks Analyst Blog Highlights: Abbott Labs, Bristol-Myers Squibb, Biogen …Sacramento BeeAbbott Labs, along with partner Biogen (Nasdaq: BIIB), moved daclizumab into a phase III study for the treatment of relapsing-remitting multiple sclerosis (RR…
SCLEROSI MULTIPLA – Biogen Idec-Abbott. DACLIZUMAB HYP: POSITIVI I RISULTATI … – Salus
SCLEROSI MULTIPLA – Biogen Idec-Abbott. DACLIZUMAB HYP: POSITIVI I RISULTATI …SalusI dati relativi allo studio SELECT sono stati divulgati oggi, sabato 22 ottobre 2011, durante la presentazione intitolata “Uno studio randomizzato, in doppio cieco, …